Cardiocore Selected as Preferred Provider

Article

Company News Release

Cardiocore, a centralized cardiac testing lab, announced its preferred provider status with a top 10 pharmaceutical company. Cardiocore was awarded cardiac safety service contracts in multi-year studies including a Thorough QT study and retrospective paper ECG analyses.

This is the company's second such announcement in the past three months. It had previously announced it was selected by an unnamed top 10 biotech.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.